Evidence of the folate‐mediated one‐carbon metabolism pathway genes in controlling the non‐syndromic oral clefts risks-Reference-Cited by-同舟云学术

Evidence of the folate‐mediated one‐carbon metabolism pathway genes in controlling the non‐syndromic oral clefts risks

Published:2021-11-18 Issue: Volume: Page:
ISSN:1354-523X
Container-title:Oral Diseases
language:en
Short-container-title:Oral Dis

Author:

Wang Siyue¹^ORCID,Shi Jiayu²,Liu Chunfang³,Wang Ping¹,Wang Mengying¹^ORCID,Li Wenyong¹,Zhou Ren¹^ORCID,Zheng Hongchen¹,Jiang Jin¹,Li Nan⁴,Li Jing⁴,Zhou Zhibo⁴,Zhu Hongping⁴,Wu Yiqun¹,Jia Zhonglin⁵^ORCID,Wu Tao¹⁶^ORCID,Hu Yonghua¹,Beaty Terri H.⁷

Affiliation:

1. Peking University Health Science Center Beijing China

2. Division of Growth and Development and Section of Orthodontics School of DentistryUniversity of California Los Angeles USA

3. BaoTou Medical College Baotou China

4. Peking University School of Stomatology Beijing China

5. State Key Laboratory of Oral Diseases and National Clinical Research Center for Oral Diseases and Department of cleft lip and palate West China Hospital of StomatologySichuan University Chengdu China

6. Institute of Reproductive and Child Health/Key Laboratory of Reproductive HealthNational Health Commission of the People’s Republic of China Beijing China

7. School of Public HealthJohns Hopkins University Baltimore Maryland USA

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

General Dentistry,Otorhinolaryngology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/odi.14068

Reference41 articles.

1. Genetic identification of familial hypercholesterolemia within a single U.S. health care system

2. Association of Whole-Genome and NETRIN1 Signaling Pathway–Derived Polygenic Risk Scores for Major Depressive Disorder and White Matter Microstructure in the UK Biobank

3. A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4

4. An Expanded View of Complex Traits: From Polygenic to Omnigenic

5. Developing and evaluating polygenic risk prediction models for stratified disease prevention